aTYR PHARMA INC Lessee, Operating Lease, Liability, Undiscounted Excess Amount
aTYR PHARMA INC (ATYR) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $5.64 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2024-11-07
- 2024-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.64M.
- 2024-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.90M.
- 2024-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.17M.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.29M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2024-09-30 | $5.64M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.90M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $6.17M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $6.29M 10-K · filed 2024-03-14 |
| 2023-09-30 | $6.47M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $6.40M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $6.68M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.91M 10-K · filed 2023-03-14 |
| 2022-09-30 | $7.02M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $34.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $58.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $88.00K 10-K · filed 2022-03-15 |
| 2021-09-30 | $122.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $162.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $207.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $258.00K 10-K · filed 2021-03-24 |
| 2020-09-30 | $312.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $372.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $436.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $505.00K 10-K · filed 2020-03-26 |
| 2019-09-30 | $578.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $654.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $734.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |